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Abstract The hepatic asialoglycoprotein receptor, a non-
covalent hetero-oligomer of two subunits, is a constitutively
cycling endocytic receptor. However, the ligand asialoorosomu-
coid caused downregulation of up to 40% of surface binding sites
and a twofold increase in internalization rate. This was not the
result of receptor crosslinking, since monovalent ligands had the
same effect. Ligand binding thus appears to transmit a signal to
the cytosolic portion of the receptor not unlike in signaling
receptors. The two subunits were endocytosed at different
average rates lower than that of ligand, indicating heterogeneity
in oligomer formation and potentially in ligand specificity.
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1. Introduction
Receptors internalized via clathrin-dependent endocytosis
can be divided into two classes. Signal-transducing receptors,
such as peptide hormone receptors, are internalized in a lig-
and-dependent manner. Since they transduce a signal to the
cytoplasm, endocytosis serves to terminate the signal by dis-
sociation and/or degradation of the ligand-receptor complex,
and to desensitize the cell by reducing the number of available
receptors on the cell surface. In contrast, transport receptors
involved in the uptake of macromolecules, such as transferrin,
low density lipoproteins (LDL), mannose-conjugated proteins,
and asialoglycoproteins (ASGPs), cycle constitutively between
the plasma membrane and endosomes both in the presence
and in the absence of their ligands [1^4]. For both classes,
clustering in clathrin-coated pits depends on cytosolic deter-
minants, of which the tyrosine- and dileucine-containing mo-
tifs are the best characterized (reviewed in [5,6]). These motifs
are recognized by clathrin-associated adaptor complexes (re-
viewed in [7]). The ligand-dependent activity of endocytosis
motifs in signaling receptors may be regulated by a conforma-
tional change in the cytoplasmic domain [5], by receptor oli-
gomerization that increases the valency of the internalization
motif, and/or by a release of receptors from membrane do-
mains incompetent for endocytosis (as in the case of the in-
sulin receptor [8]). In contrast, the signals of constitutively
cycling receptors are continuously exposed.
We have analyzed the distribution and internalization ki-
netics of the ASGP receptor, an endocytic transport receptor
of hepatocytes which removes galactose-terminal (desialyl-
ated) glycoproteins with tri- or tetra-antennary N-linked gly-
cans from the circulation [9,10]. The receptor consists of two
homologous subunits (called H1 and H2 in the human sys-
tem), which are both required to form high-a⁄nity ASGP
binding sites [11,12]. Despite numerous approaches, the exact
stoichiometry of the subunits in the functional receptor com-
plex has not been unambiguously determined. Based on the
accumulated data, the minimal ASGP receptor complex must
contain two H1 and one H2 [13]. Ligand uptake and receptor
internalization are mediated by a tyrosine-containing endocy-
tosis signal in the 40 amino acid cytosolic domain of subunit
H1 [14,15]. Initial evidence for constitutive cycling of this
receptor was obtained in studies on the e¡ect of lysosomo-
tropic agents on receptor tra⁄c in hepatocytes and HepG2
cells [4,16^18]. These agents caused downregulation of surface
receptors by inhibiting or blocking their recycling from endo-
somes back to the cell surface. In these experiments, it was
observed that the disappearance of ASGP binding sites in
chloroquine-treated cells was more rapid in the presence of
ligand than in its absence [18], suggesting a stimulatory e¡ect
of ligand binding on endocytosis.
In this study, we analyzed the e¡ect of ligand directly. Lig-
and caused downregulation of surface binding sites by in-
creasing the internalization rate of the receptor. Surprisingly,
the internalization rates of H1 and H2 with and without lig-
and were di¡erent from each other and from that of ligand
alone, indicating heterogeneity in the composition of ASGP
receptor subunit complexes.
2. Materials and methods
2.1. Cell culture
Cell culture reagents were purchased from Gibco. The human hep-
atoma cell line HepG2 was grown in Eagle’s minimal essential me-
dium with 10% fetal bovine serum supplemented with 2 mM L-gluta-
mine, 100 U/ml penicillin, and 100 Wg/ml streptomycin.
2.2. Ligand binding and internalization
Asialoorosomucoid (ASOR) was prepared and 125I-iodinated as
described [12]. Ligand binding was performed at 4‡C for 2 h using
2 Wg/ml [125I]ASOR or [125I]MGP in HEPES-bu¡ered saline contain-
ing 1.7 mM CaCl2 and 0.2 mg/ml cytochrome c. Speci¢c (i.e. Ca2-
dependent) binding was determined by stripping bound ligand with
5 mM EDTA at 4‡C for 20 min. Non-speci¢c binding was always less
than 15% of total binding. After ligand binding and washing, the cells
were incubated at 37‡C to allow endocytosis. Surface ligand was
stripped with 5 mM EDTA and internalized ligand was quanti¢ed
by counting cell-associated radioactivity.
Downregulation of binding sites was assayed by incubating the cells
at 37‡C for 15 or 30 min with ASOR or a complex-type, triantennary,
desialylated N-linked oligosaccharide (from Oxford Glycosystems,
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Oxford, UK). Surface ligand was stripped with 5 mM EDTA at 4‡C
and surface binding sites determined by [125I]ASOR binding as de-
scribed above.
2.3. Receptor internalization
Internalization of the ASGP receptor subunits H1 and H2 was
analyzed by the surface iodination and protease protection assay de-
scribed by Ge¡en et al. [20]. Brie£y, the cell surface was labeled at 4‡C
using the impermeant, 125I-iodinated reagent sulfosuccinimidyl-3-
(4-hydroxyphenyl) propionate (SSHPP; from Pierce) and, after incu-
bation at 37‡C for di¡erent times, digested at 4‡C with proteinase K.
Protease-resistant labeled receptor subunits were analyzed by immu-
noprecipitation, SDS-gel electrophoresis, and quantitative autoradiog-
raphy using a phosphoimager. To study the e¡ect of prebound ligand
on internalization, cells were incubated for 2 h at 4‡C with or without
10 Wg/ml ASOR before surface labeling. To distinguish the two sub-
units, antibodies raised against synthetic peptides corresponding to
residues 277^286 of H1 or 300^309 of H2 were used (anti-H1 and
anti-H2, respectively). Initial endocytosis rates were calculated based
on the earliest time point measured (after 1 or 2 min). To assess the
e¡ect of surface iodination on receptor functionality, binding and
uptake of [125I]ASOR were performed using cells treated with non-
radioactive iodinated SSHPP. The stability of ligand binding was
tested by ¢rst binding [125I]ASOR to HepG2 cells, labeling the cells
with non-radioactive iodinated SSHPP. Cell-associated [125I]ASOR
was measured before and after incubating the cells at 4‡C for 2 h in
the presence of 200 Wg/ml cold ASOR. The surface iodination proce-
dure had no signi¢cant e¡ect on the number of ligand binding sites,
on binding stability, and on the internalization rate (not shown).
2.4. Monoglycosylated peptide (MGP)
The peptide corresponding to residues 175^184 of asialofetuin was
puri¢ed and 125I-iodinated according to Bider et al. [19]. Matrix-as-
sisted laser desorption ionization time-of-£ight (MALDI-TOF) mass
spectrometry was performed on a Vestec Benchtop II instrument in
negative ion mode with 25 kV accelerating voltage and 337 nm laser
wavelength. Aliquots of MGP (3 nmol in 1 Wl 50 mM sodium citrate/
phosphate bu¡er, pH 5, containing 25 mM zinc chloride) were incu-
bated without or with neuraminidase (0.2 mU), or with neuraminidase
and L-galactosidase (from bovine testes, 1.4 mU; both from Boehr-
inger Mannheim) at 37‡C for 23 h. Samples were mixed with an equal
volume of saturated sinapic acid in water and dried onto the sample
plate. For calibration, oxidized insulin chains A and B (Sigma) were
used. 3. Results
3.1. Ligand-induced downregulation of surface binding sites
An e¡ect of ligand on receptor cycling will be re£ected in
the number of ASGP receptors at the cell surface. To deter-
mine the number of surface binding sites upon ligand expo-
sure, HepG2 cells were ¢rst incubated with di¡erent concen-
trations of ASOR at 37‡C for 15 min (which is the average
cycle time of the receptor in the presence of ligand [21]),
washed at 4‡C with EDTA to release bound unlabeled
ASOR and incubated for 2 h with 125I-labeled ASOR. The
measured numbers of surface ASOR-binding sites were plot-
ted as a percentage of cells preincubated without ligand (Fig.
1A). A concentration-dependent downregulation of up to 40%
of the surface binding sites was observed with a half-maximal
e¡ect at approximately 0.1 WM ASOR.
To compare endocytosis of ligand-receptor complexes and
free receptor protein, the internalization rates of [125I]ASOR
and of surface-labeled unoccupied receptor were measured.
[125I]ASOR was prebound at 4‡C to receptors on the cell sur-
face and then allowed to endocytose at 37‡C for di¡erent
times. After removal of surface ligand by washing with
EDTA, internalized [125I]ASOR was quanti¢ed and plotted
as a percentage of initially bound ligand (Fig. 2A, ¢lled
squares). Bound ligand was internalized at an initial rate of
V26%/min. To measure the constitutive rate of receptor in-
ternalization, surface receptors were labeled with the amino
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Fig. 1. Ligand-induced downregulation of surface ASGP-binding
sites in HepG2 cells. Cells were incubated at 37‡C for 15 min with
the indicated concentration of ASOR or of a triantennary, galac-
tose-terminal oligosaccharide (Glycan). At 4‡C, any bound ligand
was released with EDTA and the total surface binding sites were
determined with [125I]ASOR in the presence of CaCl2 (as described
in Section 2). The results are expressed in percent of binding sites
on cells preincubated in the absence of ligand. The means of dupli-
cate determinations are shown in panel A, and of triplicate determi-
nations with standard deviations in panel B.
Fig. 2. Internalization kinetics of unoccupied ASGP receptor,
ASOR, and MGP. A: Internalization of prebound [125I]ASOR (F)
and [125I]MGP (E) was measured as described in Section 2. The
means and range of 2^5 determinations are shown. B: The constitu-
tive endocytosis of the ASGP receptor was determined using the
surface iodination/protease protection assay with an antiserum
against both receptor subunits. The means and standard deviations
of triplicate determinations are shown. The £uorograph of the SDS
gel is shown in the inset.
M.D. Bider, M. Spiess/FEBS Letters 434 (1998) 37^4138
group-speci¢c, membrane-impermeant reagent [125I]SSHPP at
4‡C and then incubated at 37‡C for di¡erent times. Receptors
at the cell surface were digested with proteinase K at 4‡C, and
the resistant, labeled receptors were immunoprecipitated with
an antiserum recognizing both subunits, and quanti¢ed (Fig.
2B). Surface labeled receptor protein acquired protease resist-
ance with an initial rate of V7%/min. The total receptor
protein in the absence of ligand was thus internalized at a
rate of less than one third of that of ligand-receptor com-
plexes, suggesting a dramatic induction of endocytosis by lig-
and.
The ligands generally used to measure ASGP binding and
internalization, ASOR and asialofetuin, are glycoproteins
with ¢ve and three N-linked glycans, respectively. A possible
explanation for the ligand-induced increase in receptor inter-
nalization is the physical crosslinking of receptors by the mul-
tivalent ligands. To test this possibility, we determined the
e¡ect of a puri¢ed, desialylated, triantennary oligosaccharide
of the N-linked type on ASGP receptor distribution. As
shown in Fig. 1B, also the free glycan induced a signi¢cant
downregulation of surface ASOR-binding sites. At a glycan
concentration of 3 WM, the reduction was similar to that of
ASOR at 1 WM (corresponding to 5 WM of bound N-linked
oligosaccharides).
To directly measure the internalization rate of a monova-
lent ligand, we puri¢ed a MGP of asialofetuin [19]. The en-
doproteinase Glu-C fragment corresponding to residues 175^
184 contains one of the N-glycans and a tyrosine that could be
labeled with [125I]iodine. MALDI-TOF mass spectrometry of
this puri¢ed MGP recorded a single major species with a
molecular mass of 3087, which is within the accuracy of the
measurement of the calculated mass of 3098 (Fig. 3). Neur-
aminidase treatment did not alter the observed mass, whereas
additional partial digestion with L-galactosidase revealed three
steps of mass reduction of 162 each, corresponding to the
mass of galactose. This con¢rmed that the glycan of MGP
was triantennary and completely desialylated. Most impor-
tantly, contamination by products of incomplete proteolysis
that might contain more than one glycan could not be de-
tected in the entire mass range up to 68 000 (inset). Internal-
ization of 125I-iodinated, prebound MGP proceeded with an
initial rate of V25%/min (Fig. 2A, open squares), which is
very similar to that of [125I]ASOR. Hence, receptor crosslink-
ing by ligand contributes little, if at all, to the rate of internal-
ization.
3.2. Heterogeneity of ASGP receptor complexes
The direct comparison of the internalization rate of recep-
tor protein without ligand with that of ligand-receptor com-
plexes is only possible if the receptor proteins constitute a
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Fig. 3. Characterization of the puri¢ed MGP by mass spectrometry. MALDI-TOF mass spectrometry of the puri¢ed MGP without and with
incubation with neuraminidase and L-galactosidase was performed as described in Section 2.
Fig. 4. Internalization kinetics of the receptor subunits H1 and H2
in the presence or absence of bound ASOR. The constitutive endo-
cytosis of H1 (A) and H2 (B) in the absence (open symbols) or
presence (¢lled symbols) of ligand was determined using the surface
iodination/protease protection assay with subunit-speci¢c antisera.
The means and ranges of 2^3 determinations are shown.
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homogeneous receptor population. Since the two subunits of
the ASGP receptor have the potential to form homo-oligom-
ers that are unable to bind ASOR [12,14,15], this condition is
not necessarily ful¢lled. We therefore separately analyzed the
internalization rates of subunits H1 and H2 in HepG2 cells.
Receptor subunits at the cell surface were preincubated with
or without ASOR at 4‡C, labeled with [125I]SSHPP at 4‡C
followed by internalization at 37‡C for di¡erent times, pro-
teinase K digestion at 4‡C, and subunit-speci¢c immunopre-
cipitation of resistant H1 and H2 using antibodies raised
against synthetic peptides corresponding to the C-terminal
sequences of the subunits. In control experiments, we found
that modifying the cell surface with non-radioactive iodinated
SSHPP did not reduce the number of binding sites for
[125I]ASOR, the stability of its binding, or the rate of its in-
ternalization (not shown). In the absence of ligand (Fig. 4,
open circles), subunit H1 was internalized twice as fast as
H2 with initial rates of V8%/min for H1 vs. V4%/min for
H2. This is not consistent with the notion that all subunits are
assembled in a single type of receptor complex, but rather
indicates heterogeneity in subunit oligomerization. Ligand
binding increased the rates of both subunits approximately
twofold (Fig. 4, ¢lled circles) to V16%/min for H1 and to
V8%/min for H2, con¢rming that both subunits are part of
ligand binding receptor complexes. However, both subunits
had a clearly lower average internalization rate than ligand
itself, indicating that both subunits are also present in alter-
native subunit complexes not binding and not internalizing
ASOR-binding sites.
4. Discussion
Transport receptors are characterized by constitutive inter-
nalization. However, only in a few cases have internalization
rates in the presence and absence of ligand been quanti¢ed.
For the transferrin receptor, there is clear evidence (despite an
early publication to the contrary [22]) that ligand binding does
not signi¢cantly alter receptor internalization [2,23] or coated
pit localization [24]. Analysis of the LDL receptor did not
suggest a ligand e¡ect on the internalization rate per se [1],
but experiments using monensin to inhibit recycling indicated
a fraction of LDL receptors that do not cycle at all unless
ligand is added [25]. The situation for the ASGP receptor is
di¡erent, since monensin experiments showed that ASOR-
binding sites constitute a single constitutively cycling pool
[18]. Binding ASOR, however, induced the downregulation
of up to 40% of these binding sites (Fig. 1) and approximately
doubled the internalization rate of the receptor subunits (Fig.
4). This e¡ect is not due to a simple crosslinking mechanism
via ligand, since a monovalent glycopeptide was internalized
with essentially the same kinetics as a multivalent ligand (Fig.
2).
That ligand binding strongly stimulates endocytosis of a
constitutive receptor suggests that the distinction between
transport and signaling receptors may not be as strict as gen-
erally assumed. Interestingly, Fallon et al. reported coimmu-
noprecipitation of a protein kinase activity with the ASGP
receptor and with subunit H1 alone [26,27]. They proposed
that an extrinsic kinase comparable to the intrinsic kinase in
peptide hormone receptors might perform a regulatory func-
tion in tra⁄cking of transport receptors. In this model, ligand
binding might activate the associated kinase via a conforma-
tional change, thereby enhancing the association with clathrin
coats. A ligand e¡ect on the kinase activity remains to be
demonstrated.
Previous studies revealed that tyrosine-5 of H1 in the cyto-
plasmic domain is necessary for constitutive as well as ligand
internalization [14,15]. Ligand binds to the exoplasmic carbo-
hydrate recognition domain (CRD) at the C-terminus. The
subunits are oligomerized via a coiled-coil domain [28,29]
that forms a stalk of approximately 12 nm on top of which
the CRDs are presented. For high-a⁄nity binding, at least
three CRDs in a receptor complex interact each with a termi-
nal galactose in the desialylated N-linked glycan. To induce
increased internalization of the receptor complex, binding of
ligand is likely to transmit a conformational change across the
membrane to alter the exposure of the endocytosis signals or
to in£uence putative associated proteins. The coiled-coil stalk
domain and its transmembrane extension might transmit a
ligand-induced change in the relative position of the CRDs
across the membrane to the cytoplasmic portion of the sub-
units, possibly by a slight relative rotation of the K-helices in
the coiled-coil.
Surprisingly, we found that the internalization rates of the
two receptor subunits were di¡erent and, even with bound
ASOR, lower than the rate of ASOR itself (Fig. 4). This
suggests the existence of ASOR-binding and non-binding re-
ceptor complexes with di¡erent subunit compositions. In £u-
orescence photobleaching recovery experiments, immobiliza-
tion of either H1 or H2 by antibody crosslinking led to an
equal immobilization of the other subunit, indicating that
most of H1 and H2 in HepG2 cells is assembled in stable
hetero-oligomers [30]. In vitro analysis of the oligomerization
speci¢city of the puri¢ed coiled-coil domains of H1 and H2
revealed the preferred formation of 2 H1:2 H2 as well as 1:3
hetero-tetramers [29]. Since it was shown by ligand-receptor
crosslinking that two of the galactoses in a triantennary ligand
speci¢cally interact with the rat homolog of H1 and the third
galactose with H2 [31], only the 2:2 oligomers are potential
ligand binding complexes. 1:3 hetero-oligomers are thus can-
didates to account for the populations of H1 and H2 which
are internalized but are not part of ASOR-binding receptor
complexes. Endocytosis has been shown to be mediated by the
tyrosine signal in H1, whereas H2 did not signi¢cantly con-
tribute to internalization [15]. Thus, 2:2 complexes, which
contain two copies of the H1 endocytosis signal, are expected
to internalize more e⁄ciently than 1:3 complexes with only
one copy. Since H2 is more abundant in the latter oligomers
than H1, this could explain that the average internalization
rate of H2 is lower than that of H1.
The CRDs of H1 and H2 both recognize terminal galactose.
Hetero-oligomerization is likely to be necessary for the precise
asymmetric presentation of the individual CRDs’ galactose-
binding sites to ¢t the arrangement of the galactoses in the
ligand [13,31]. The ¢nding that the ASGP receptor subunits
form di¡erent oligomeric complexes with distinct ASGP-bind-
ing capabilities raises the possibility that as yet unidenti¢ed
ligands exist. Most studies to test natural and synthetic gly-
cans for binding to the ASGP receptor were performed as
competition experiments in which the inhibition of the bind-
ing of radioactive ASOR or asialofetuin (i.e. triantennary,
desialylated N-linked glycans) was assessed. Interaction with
distinct binding sites would thus have gone undetected. Our
results raise the possibility that alternative oligosaccharide
FEBS 20709 27-8-98
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ligands exist, speci¢c for those ASGP receptor complexes that
do not bind ASOR.
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